RP-001 not checked

Recurv Pharma Inc

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
1 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Advanced Malignancies, Oncology, Colorectal Cancer, Pancreatic Cancer, Cancer
Main trialPhase 1/2
“Phase 1/2a Study of RP-001 in participants with Advanced Malignancies”In the company’s words, NCT07504263 on ClinicalTrials.gov

Other drugs for Advanced Malignancies

All 195 drugs for Advanced Malignancies

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials1

TrialPhaseCompletesWhat it tests
Phase 1/2Not yet recruiting 1 Dec 2027 Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow RP-001

Following is part of Solo: you see every change to RP-001 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in